000 | 00907 a2200253 4500 | ||
---|---|---|---|
005 | 20250514084429.0 | ||
264 | 0 | _c20030501 | |
008 | 200305s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(53)90885-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGALTON, D A | |
245 | 0 | 0 |
_aMyleran in chronic myeloid leukaemia; results of treatment. _h[electronic resource] |
260 |
_bLancet (London, England) _cJan 1953 |
||
300 |
_a208-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBusulfan |
650 | 0 | 4 |
_aGlycols _xtherapeutic use |
650 | 0 | 4 | _aLeukemia |
650 | 0 | 4 | _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive |
650 | 0 | 4 |
_aLeukemia, Myeloid _xtherapy |
773 | 0 |
_tLancet (London, England) _gvol. 264 _gno. 6753 _gp. 208-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(53)90885-x _zAvailable from publisher's website |
999 |
_c12865050 _d12865050 |